Showing results (11-20 of 788) with videos related to

Sort By:
Pageof 79
Therapeutic Advances in Musculoskeletal Disease|December 2, 2024
Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imagingXenofon Baraliakos, Jerney de Jongh, Denis Poddubnyy, et al.
Therapeutic Advances in Musculoskeletal Disease|December 18, 2024
The analysis of the pulmonary domain involvement in Sjögren's diseaseMarta Madej, Krzysztof Proc, Piotr Wawryka, et al.
Therapeutic Advances in Musculoskeletal Disease|February 18, 2025
Incidence rate of and risk factors for glomerulonephritis in patients with axial spondyloarthritis: a nationwide population-based studySubin Hwang, Ye-Jee Kim, Soo Min Ahn, et al.
Therapeutic Advances in Musculoskeletal Disease|November 4, 2024
Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trialStefan Siebert, Georg Schett, Siba P Raychaudhuri, et al.
Therapeutic Advances in Musculoskeletal Disease|December 21, 2020
Re-appraising the potential of naringin for natural, novel orthopedic biotherapiesKristin E Yu, Kareme D Alder, Montana T Morris, et al.
Therapeutic Advances in Musculoskeletal Disease|December 21, 2020
Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitusGeorge E Fragoulis, Gerasimos Evangelatos, Nikolaos Tentolouris, et al.
Therapeutic Advances in Musculoskeletal Disease|January 4, 2020
Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trialsWenhui Xie, Shiyu Xiao, Yanrong Huang, et al.
Therapeutic Advances in Musculoskeletal Disease|October 31, 2019
A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritisAlan Kivitz, Louis Kwong, Tammi Shlotzhauer, et al.
Therapeutic Advances in Musculoskeletal Disease|December 12, 2022
The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunitiesHeungdeok Kim, Jinwon Seo, Yunsin Lee, et al.
Therapeutic Advances in Musculoskeletal Disease|July 15, 2021
Comparison of healthcare resource utilization and medical costs between patients with seropositive and seronegative rheumatoid arthritisHyoungyoung Kim, Soo-Kyung Cho, Seongmi Choi, et al.
Pageof 79